Weed Inc(BUDZ)
USD --+0.00%
Reward27Low
Risk80High
📊75%Data
BUDZ
+0.0 · +0.00%
USD · OTCQB
Weed Inc | Healthcare
Capital Destroyer
Market Cap:5.93M
ℹ️
Reward Rating
27
Low
Bottom 1% (model universe)
75% data coverage
ℹ️
Risk Rating
80
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BUDZ to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Weed Inc?

, together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.

BUDZ · Verdict

Limited reward · high risk

BUDZ has limited near-term tailwinds — cash flow and profitability weigh on the model output.

Based on 88% data coverage

BUDZ · Verdict

What’s working & what to watch

Watchouts 5

  • Cash flow5/100

    Weak vs peers

  • Profitability10/100

    -2978% return on equity

  • Balance sheet11/100

    Current ratio 0.04

  • Growth18/100

    Earnings -3.5% CAGR

  • Valuation34/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Weed Inc?

, together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia. The company was formerly known as United Mines, Inc. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 5.93M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Low (27)

The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap5.93M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0848
52 Week Low0.0159
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding148M
No. of Employees2
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTCQB
Beta0.846
CurrencyUSD